![]() What should I tell my health care provider before taking KISQALI?īefore you take KISQALI, tell your health care provider if you: Your health care provider may tell you to decrease your dose, temporarily stop, or completely stop taking KISQALI if you develop certain serious side effects during treatment with KISQALI. Tell your health care provider right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills. ![]() Your health care provider should check your white blood cell counts before and during treatment with KISQALI. Low white blood cell counts (neutropenia). Low white blood cell counts are very common during treatment with KISQALI and may result in infections that may be severe. bleeding or bruising more easily than normal.pain on the right side of your stomach area (abdomen).yellowing of your skin or the whites of your eyes (jaundice).Tell your health care provider right away if you get any of the following signs and symptoms of liver problems: Your health care provider should do blood tests to check your liver before and during treatment with KISQALI. KISQALI can cause serious liver problems. Tell your health care provider right away if you have a change in your heartbeat (a fast or irregular heartbeat), or if you feel dizzy or faint. Your health care provider should check your heart and do blood tests before and during treatment with KISQALI. This condition can cause an abnormal heartbeat and may lead to death. Heart rhythm problems (QT prolongation). KISQALI can cause a heart problem known as QT prolongation. Severe skin reactions. Tell your health care provider or get medical help right away if you get severe rash or rash that keeps getting worse reddened skin flu-like symptoms skin pain/burning blistering of the lips, eyes, or mouth or blisters on the skin or skin peeling, with or without fever. trouble breathing or shortness of breath.Tell your health care provider right away if you have any new or worsening symptoms, including: KISQALI may cause severe or life-threatening inflammation of the lungs during treatment that may lead to death. KISQALI may cause serious side effects, including: What is the most important information I should know about KISQALI? It is not known if KISQALI is safe and effective in children. ![]() fulvestrant as the first endocrine-based therapy or following disease progression on endocrine therapy in postmenopausal women or in men.an aromatase inhibitor as the first endocrine-based therapy or.KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (metastatic), in combination with:
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |